Barclays Maintains Overweight on Exelon, Lowers Price Target to $36
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Eric Beaumont has maintained an Overweight rating on Exelon (NASDAQ:EXC) but has reduced the price target from $38 to $36.

January 22, 2024 | 3:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays has maintained an Overweight rating on Exelon but lowered the price target from $38 to $36.
While the Overweight rating suggests confidence in Exelon's performance, the reduction in price target may indicate a tempered expectation for the stock's growth potential. This could lead to a neutral short-term impact as the positive rating is counterbalanced by a lower price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100